PierianDx Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 198
Employees
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 14

PierianDx General Information

Description

Developer of a cloud-based clinical software designed to facilitate research on sequencing testing process. The company's software uses automated actionable Intelligence and automates the process of taking DNA sequencing data through analysis, interpretation and final report, enabling the healthcare industry to improve the medical procedures with advanced precision medicine.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Media and Information Services (B2B)
Primary Office
  • 6 Cityplace
  • Creve Coeur, MO 63141
  • United States
+1 (314) 000-0000

PierianDx Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PierianDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 27-Aug-2020 000.00 Completed Generating Revenue
2. Later Stage VC (Series B) 13-Nov-2019 0000 000.00 00000 Completed Generating Revenue
1. Early Stage VC (Series A) 08-Dec-2015 $14.2M $14.2M 000.00 Completed Generating Revenue
To view PierianDx’s complete valuation and funding history, request access »

PierianDx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A1 Exchange 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A1 45,000,000 $0.001000 $0.02 $0.15 $0.15 1x $0.15 28.7%
Series A 4,500,000 $0.001000 $0.28 $3.46 $3.46 1x $3.46 2.87%
To view PierianDx’s complete cap table history, request access »

PierianDx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a cloud-based clinical software designed to facilitate research on sequencing testing process. The company'
Decision/Risk Analysis
Creve Coeur, MO
198 As of 2020
000.00
0000000000 0 000.00

00000000

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo co
00000 0000000000 0000000000 0000000
Helsinki, Finland
00 As of 0000
00.000
0000000000 0 00.000

000000 0

sum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolor
0000000000000 00000000
Oakland, CA
00 As of 0000
000.00
000000000 - 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PierianDx Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MediSapiens Venture Capital-Backed Helsinki, Finland 00 00.000 0000000000 0 00.000
000000 00000000 Venture Capital-Backed Oakland, CA 00 000.00 000000000 - 000.00
00000000 Formerly PE-Backed Harderwijk, Netherlands 00 000000 - 000
000000000 Corporation Cambridge, United Kingdom 00 0000000000
0000000 Formerly VC-backed Rijswijk, Netherlands 00 000.00 000000&0 000.00
You’re viewing 5 of 13 competitors. Get the full list »

PierianDx Executive Team (17)

Name Title Board Seat Contact Info
Mark McDonough Chief Executive Officer & Board Member
Rakesh Nagarajan Ph.D Co-Founder, President, Chief Vision Officer & Chief Technology Officer
James Starr Chief Financial Officer
Chris Callahan Chief Operating Officer & Executive Vice President
Andy Bredemeyer Ph.D Vice President, Product
You’re viewing 5 of 17 executive team members. Get the full list »

PierianDx Board Members (12)

Name Representing Role Since
Bryan Carey Health Catalyst Capital Management Board Member 000 0000
Charles Boorady Self Chairman 000 0000
Cody Nystrom SJF Ventures Board Observer 000 0000
Frederick Hessler Self Board Member 000 0000
John Niederhuber MD PierianDx Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

PierianDx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PierianDx Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Album VC Venture Capital Minority 000 0000 000000 0
ATW Partners Venture Capital Minority 000 0000 000000 0
Health Catalyst Corporation Minority 000 0000 000000 0
Intermountain Ventures Corporate Venture Capital Minority 000 0000 000000 0
RTI International Corporation Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

PierianDx Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 00000000 12-Oct-2016 000000000000000000 Social/Platform Software 000 0000000 00.0
To view PierianDx’s complete acquisitions history, request access »